Suchergebnisse - "Famorca, Leilani"

PubPharm (7)

1

CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis : 2022 addendum

enthalten in: Rheumatology (Oxford, England) | 2023

von Turgeon, D. | Bakowsky, V. | Baldwin, C. | +28

CommentIn: Rheumatology (Oxford). 2023 Aug 1;62(8):2633-2634. - PMID 37084252

2

CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis : 2020 Update

enthalten in: The Journal of rheumatology | 2021

von Mendel, A. | Ennis, D. | Go, E. | +34

CommentIn: J Rheumatol. 2021 Apr;48(4):479-481. - PMID 33649076

3

Assessment of Disease Activity in Large-vessel Vasculitis : Results of an International Delphi Exercise

enthalten in: The Journal of rheumatology | 2017

von Aydin, S. | Direskeneli, H. | Merkel, P. | +101

4

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides

enthalten in: The Journal of rheumatology | 2016

von McGeoch, L. | Twilt, M. | Famorca, L. | +25

5

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides – Executive summary

enthalten in: Canadian journal of kidney health and disease | 2015

von McGeoch, L. | Twilt, M. | Famorca, L. | +24

6

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summary

enthalten in: Canadian journal of kidney health and disease | 2015

von McGeoch, L. | Twilt, M. | Famorca, L. | +25

7

Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides : Results of the National Needs Assessment Questionnaire

enthalten in: The open rheumatology journal | 2015

von Famorca, L. | Twilt, M. | Barra, L. | +20

1
[1]